Main Article Content

Diabetes and COVID-19 in Congolese patients

Henriette Poaty
Guy Emergence Poaty
Gilbert NDziessi
Emile Godefroy Ngakeni
Tatiana Doukaga Makouka
René Soussa Gadoua
Regis Ondzé
Lambert Kitembo
Presley Jeanel Msengui
Jethro Massala Peya
Michel Gbala Sapoulou
Pascal Ibata
Henri Germain Monabeka
Alexis Elira Dokekias


Background: The global pandemic Coronavirus Disease 2019 (COVID-19) due to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is reported to be potentially severe in patients with morbid conditions. One common reported comorbidities is diabetes. We aimed in this study to precise the clinical characteristics and outcomes in a series of congolese diabetic patients affected by COVID-19 infection.

Patients and methods: We retrospectely studied from 256 COVID-19 patients, a cohort of 30 persons with previously known diabetes. The glycaemia controls have been obtained by plasma glucose assay. All patients have been tested positive to SARS-CoV-2 by RT-PCR method.

Results: The COVID-19 diabetic patients represented 11,7% of all COVID-19 patients with confidence interval of 95% [7,77-15,65]. Older individuals and male sex were predominent. Dyspnea and sauration of oxygen < 90 were significatives and added risk factors were noted in 63.3% of patients, particulary hyperglycaemia with hypertension or obesity. The mortality rate at the percentage of 36.7% was more prevalent in patients with added comorbidities (30%) versus without comorbidities (6.7%).

Conclusion: Congolese COVID-19 diabetic patients of male sex and older age exhibiting arterial hypertension and obesity are the most exposed to severe COVID-19 and increasead mortality rate.

Keywords: COVID-19, SARS-CoV-2, diabetes, Congolese patients.

Journal Identifiers

eISSN: 1729-0503
print ISSN: 1680-6905